BioNTech SE (BNTX) — the peer cohort
As of 2026-10-26 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
BioNTech SE ranks 16 of 16 in its cohort on the Closelooknet composite (37/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| BNTX BioNTech SE | 37 | 38 | 35 | 50 | bear | 28.9% |
| ASML.AS ASML Holding N.V. | 68 | 70 | 88 | 28 | watch | 19.2% |
| SGE.L Sage Group PLC | 64 | 91 | 83 | 56 | neutral | 1% |
| PATH Uipath Inc | 63 | 77 | 59 | 51 | bear | 28.8% |
| SAP.DE SAP SE | 62 | 89 | 76 | 37 | neutral | 10.7% |
| WKL.AS Wolters Kluwer N.V. | 62 | 74 | 83 | 72 | bull | 24.3% |
| SECT-B.ST Sectra AB (publ) | 61 | 89 | 67 | 11 | bull | 0.9% |
| REL.L Relx PLC | 60 | 65 | 85 | 59 | bull | 14.9% |
| DSY.PA Dassault Systemes SE | 59 | 85 | 74 | 46 | bull | 19.5% |
| TEMN.SW Temenos Group AG | 59 | 63 | 91 | 46 | bull | 14.1% |
| ASM.AS ASM International NV | 58 | 40 | 75 | 28 | bear | 35.9% |
| NEM.DE Nemetschek AG O.N. | 58 | 61 | 75 | 39 | bull | 33.4% |
| SAN.PA Sanofi SA | 58 | 47 | 70 | 60 | watch | 14.1% |
| HALO Halozyme Therapeutics Inc | 74 | 98 | 94 | 48 | ok | 0.1% |
| BION.SW BB Biotech AG | 73 | 62 | 96 | 82 | info | 13.3% |
| UCB.BR UCB SA | 65 | 65 | 70 | 54 | info | 6.2% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-10-26
Quick answers
Who are BioNTech SE's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: ASML Holding N.V. (ASML.AS), Sage Group PLC (SGE.L), Uipath Inc (PATH), SAP SE (SAP.DE), Wolters Kluwer N.V. (WKL.AS), Sectra AB (publ) (SECT-B.ST), Relx PLC (REL.L), Dassault Systemes SE (DSY.PA) and others.
How does BNTX score against its peers?
BioNTech SE's composite reads 37/100, ranking 16 of 16 in its cohort as of 2026-10-26; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.
Related in the Closelooknet universe
same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ASML.AS ASML Holding N.V.
- SGE.L Sage Group PLC
- PATH Uipath Inc
- SAP.DE SAP SE
- WKL.AS Wolters Kluwer N.V.
- SECT-B.ST Sectra AB (publ)
- REL.L Relx PLC
- DSY.PA Dassault Systemes SE
- TEMN.SW Temenos Group AG
- ASM.AS ASM International NV
- NEM.DE Nemetschek AG O.N.
- SAN.PA Sanofi SA
- HALO Halozyme Therapeutics Incindustry
- BION.SW BB Biotech AGindustry
- UCB.BR UCB SAindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- KOD Kodiak Sciences Incindustry
- IOVA Iovance Biotherapeutics Incindustry